查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
全球質譜市場 - 2023-2030
市場調查報告書
商品編碼
1279709

全球質譜市場 - 2023-2030

Global Mass Spectrometry Market - 2023-2030
出版日期: | 出版商: DataM Intelligence | 英文 195 Pages | 商品交期: 約2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

市場概覽

全球質譜市場預計將在 2022 年達到 48.301 億美元，並在 2030 年達到 85.66 億美元，增長勢頭強勁。 預計該市場在預測期內（2023-2030 年）的複合年增長率為 7.6%。

質譜法是一種強大的技術，可根據物質的離子電荷比發現、分類和量化物質。 質譜法在這些過程中的有效性使其成為許多生物製藥公司和研究實驗室進行評估的寶貴工具。 現代質譜技術，如遷移譜和毛細管電泳，用於分離複雜的混合物，如□產品。

質譜法廣泛用於食品和飲料、製藥和生物研究領域的檢測。 新藥開發、藥物再利用和藥物製劑產量的增加正在增加製藥行業對安全和質量控製程序的需求。 更嚴格的政府法規和對質量控制的需求增加使得質譜法在各個行業中得到更頻繁的採用。

市場動態

製藥行業研發支出的增加推動了質譜市場的增長

質譜在蛋白質組學、基因組學、醫院、代謝組學和藥物發現中的廣泛應用，以及質譜儀小型化、新產品發布和技術突破的增長趨勢推動了質譜市場的增長。我來了。

隨著科學研究和開發資金的增加，蛋白質組學、藥物發現和製藥領域對質譜儀的需求預計會增加，從而推動市場增長。 另一個方面是質譜技術的進步使得獲得高分辨率和快速測試結果成為可能。 質譜儀用於多種行業，包括藥物發現研究、製藥和食品安全測試。

不斷增加的產品發布和技術進步為製造商創造了有利可圖的機會

隨著生物技術和製藥公司越來越廣泛地接受質譜法進行各種研究，它擁有巨大的市場機會。 對質譜分析產品的高需求為製造商提供了有利可圖的增長選擇。

由於生命科學領域的應用需求，質譜技術得到了發展。 質譜 MALDI-ToF 是一種臨床診斷技術，它使用先進的蛋白質模式識別方法，用於診斷疾病。 由於技術發展速度加快，預計市場將在預測期內擴大。

優質產品的定價將阻礙市場增長

中低預算的公司往往買不起這些質譜儀，從而影響了市場。 然而，質譜儀更昂貴，因為它們具有更先進的功能和特性。

除了設備的購買價格外，使系統達到行業標准通常需要大量成本。 由於技術進步和操作效率的提高，對質譜儀的需求隨著時間的推移而增加。

但是，隨著技術的進步，系統的成本也在提高。 質譜儀的最終用戶購買受其價格影響。 質譜市場主要受到這些問題的製約。

COVID-19 影響分析

對於 COVID-19，除了 COVID 之前、COVID 和 COVID 之後的情景外，價格動態（將大流行期間和之後的價格變化與 COVID 之前的情景進行比較）、供需範圍（交易限制） ，由於封鎖和後續問題導致的供需變化）；

俄烏衝突影響分析

由於該地區的主要市場參與者數量較少，估計俄烏衝突對全球質譜市場的影響較小。 然而，原材料進出口的影響預計在預測期內對全球質譜市場的增長影響不大。

內容

第一章調查方法及範圍

  • 調查方法
  • 調查目的和範圍

第 2 章定義和概述

第 3 章執行摘要

  • 按產品類型分類的摘要
  • 片段：按用途
  • 摘要：按地區

第四章市場動態

  • 影響因素
    • 主持人
      • 製藥公司的研發費用增加
      • 主要公司的新產品發布和技術進步
    • 約束因素
      • 為昂貴的產品定價
      • 設備成本高
    • 機會
      • 推出新產品並擴大技術進步
    • 影響分析

第五章行業分析

  • 波特的五力分析
  • 供應鏈分析
  • 價格分析
  • 法律法規分析

第 6 章 COVID-19 分析

  • COVID-19 分析
    • COVID-19 之前的情景
    • COVID-19 期間的情景
    • COVID-19 後或未來情景
  • COVID-19 期間的價格和動態
  • 供需範圍
  • 大流行期間與市場相關的政府舉措
  • 製造商的戰略舉措
  • 總結

第 7 章按產品類型

  • 液相色譜儀
  • 氣相色譜儀
  • 串聯質譜儀
  • 基質輔助激光解吸電離飛行時間質譜儀
  • 離子淌度質譜儀
  • 其他

第 8 章應用

  • 法醫毒理學
  • 蛋白質組學研究
  • 診斷
  • 用於臨床研究
  • 其他

第9章按地區

  • 北美
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 意大利
    • 西班牙
    • 其他歐洲
  • 南美洲
    • 巴西
    • 阿根廷
    • 其他南美洲
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 澳大利亞
    • 其他亞太地區
  • 中東和非洲

第10章競爭格局

  • 競爭場景
  • 市場情況/份額分析
  • 併購分析

第11章公司簡介

  • 安捷倫科技
    • 公司簡介
    • 按產品類型分類的產品組合和內容
    • 財務摘要
    • 主要發展狀況
  • Bruker Corporation
  • Danaher Corporation
  • Hitachi Ltd
  • JEOL Ltd
  • LECO Corporation
  • MKS Instruments
  • PerkinElmer Inc.
  • Shimadzu Corporation
  • Thermo Fisher Scientific Ltd

第12章 附錄

簡介目錄
Product Code: BT846

Market Overview

The global mass spectrometry market reached US$ 4,830.1 million in 2022 and is projected to witness lucrative growth by reaching up to US$ 8,566.0 million by 2030. The market is expected to exhibit a CAGR of 7.6% during the forecast period (2023-2030).

Mass spectrometry is an effective technique for discovering, categorizing, and quantifying substances based on the ion-charge ratio. Given its efficacy in these processes, mass spectrometry has developed into a valuable tool to assess in many biopharmaceutical companies and research organizations. To separate complicated mixtures like derived peptide products, modern mass spectrometry technologies like mobility spectrometry and capillary electrophoresis are used.

In the fields of food and beverages, pharmaceutical, and biological research, mass spectroscopy is widely used for testing. New drug development, drug repurposing, and expanded pharmaceutical formulation production have all enhanced the need for safety and quality control procedures in the pharmaceutical industry. Due to stringent government regulations and growth in the need for quality control, mass spectrometry is being employed more frequently across a variety of industries.

Market Dynamics

Rising R&D Expenditure By The Pharmaceutical Industry Drives The Growth Of The Mass Spectrometry Market.

The increased use of mass spectrometry in proteomics, genomics, hospitals, metabolomics, and pharmaceutical for drug discovery, as well as rising trends in spectrometer miniaturization, new product launches, and technological breakthroughs, are driving the growth of the mass spectrometry market.

As funding for scientific research and development rises, it is projected that demand for mass spectrometers in proteomics, drug discovery, and pharmaceuticals would increase, driving market growth. Because of advancements in mass spectroscopy technology, aspects like speedy test results with great resolution were also able to be raised. Mass spectroscopy is used in many different industries, such as drug research, pharmaceuticals, food safety testing, and others.

Growing Product Launches And Technological Advancements Create Lucrative Opportunities For Manufacturers.

There is a sizable market opportunity for mass spectrometry as it is becoming more widely accepted by biotechnology and pharmaceutical companies for various research studies. Manufacturers are going to have profitable choices for growth as demand for products utilized for mass spectrometry will be high.

As a result of the demands for applications in the life sciences, mass spectrometry technology has evolved. Mass spectrometry MALDI-ToF is a clinical diagnostic technique that uses a highly advanced method of protein pattern recognition to diagnose diseases. Due to the accelerating speed of technological development, it is therefore projected that the market would increase over the projection period.

The Premium Product Pricing Will Hamper The Growth Of The Market.

Because middle- or low-budget businesses frequently cannot afford these mass spectrometer instruments, the market is being impacted. However, because spectrometry equipment has more advanced features and functionalities, it is more expensive.

Additionally to the equipment's purchase price, there are typically significant costs associated with getting the system up to industry standards. Due to advancements in technology and increased operational efficacy, the demand for mass spectrometers has grown over time.

However, as technology has advanced, system costs have increased. The decision of end users to purchase a spectrometer is influenced by its price. The market for mass spectrometry is primarily constrained by these issues.

COVID-19 Impact Analysis

The COVID-19 analysis includes the Pre-COVID Scenario, COVID Scenario, and Post-COVID Scenario in addition to pricing dynamics (including pricing change during and after the pandemic evaluating it with pre-COVID scenarios), demand-supply spectrum (shift in demand and supply due to trading restrictions, lockdown, and afterward issues), government initiatives (initiatives to reactivate a market, industry, or sector by government bodies), and manufacturers strategic initiatives.

Russia-Ukraine War Impact Analysis

The Russia-Ukraine conflict is estimated to have a low impact on the global mass spectrometry market, owing to the low number of key market players in this region. However, the impact of the import and export of raw materials is expected to have little influence over the global mass spectrometry market growth over the forecast period.

Segment Analysis

The global mass spectrometry market is segmented based on product type, application and region.

Proteomics research from the application segment accounts for 41.7% of the market share owing to rising proteomics studies.

The study of proteins' relationships, biological functions, makeup, and architectures is known as proteomics. In comparison to genomics, proteomics offers a greater grasp of the composition and operation of the organism. However, because the expression of proteins varies with time and environmental factors, it is significantly more complicated than genomics.

Human proteins are thought to number close to a million, and many of them have post-translational modifications (PTMs) and other alterations. One-dimensional (1D) and two-dimensional (2D) gel electrophoresis (2-DE) and gel-free high-throughput screening technologies like label-free measurement of high-mass resolution tandem mass spectrometry and liquid chromatography are just a few of the proteomics techniques available.

Geographical Analysis

North America Accounted For Approximately 38.3% Of The Market Share Owing To The Strong Presence Of Major Players And Increasing Technological Advancements.

Manufacturers have chances to expand their operations in this region because of the rising demand for mass spectrometry for advancements in North America. The area has many producers and suppliers, and its rapid economic development has raised the industrial production of mass spectrometry products, which has increased the demand.

Growth is also fueled by rising technological advancements, regulatory approvals, and novel product launches. Individuals are becoming more aware of various kinds of novel studies in various fields such as proteomics, genomics, or drug discovery, leading to the expansion of the market in this region. These factors show the dominance of North America.

Competitive Landscape

The major global players in the mass spectrometry market include: Agilent Technologies, Danaher Corporation, Bruker Corporation, Hitachi Ltd, LECO Corporation, JEOL Ltd, MKS Instruments, Shimadzu Corporation, PerkinElmer Inc. and Thermo Fisher Scientific Ltd among others.

Why Purchase the Report?

  • To visualize the global mass spectrometry market segmentation based on product type, application and region, as well as understand key commercial assets and players.
  • Identify commercial opportunities by analyzing trends and co-development.
  • Excel data sheet with numerous data points of mass spectrometry market-level with all segments.
  • PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
  • Product mapping available as Excel consisting of key products of all the major players.

The global mass spectrometry market report would provide approximately 53 tables, 54 figures and 195 Pages.

Target Audience 2023

  • Manufacturers/ Buyers
  • Industry Investors/Investment Bankers
  • Research Professionals
  • Emerging Companies

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

  • 3.1. Snippet by Product Type
  • 3.2. Snippet by Application
  • 3.3. Snippet by Region

4. Dynamics

  • 4.1. Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Rising R&D expenditure by the pharmaceutical industry
      • 4.1.1.2. New product launches and technological advancements by the key players
    • 4.1.2. Restraints
      • 4.1.2.1. The premium product pricing
      • 4.1.2.2. High cost of instruments
    • 4.1.3. Opportunity
      • 4.1.3.1. Growing product launches and technological advancements
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's Five Forces Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Pricing Analysis
  • 5.4. Regulatory Analysis

6. COVID-19 Analysis

  • 6.1. Analysis of COVID-19
    • 6.1.1. Scenario Before COVID-19
    • 6.1.2. Scenario During COVID-19
    • 6.1.3. Post COVID-19 or Future Scenario
  • 6.2. Pricing Dynamics Amid COVID-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During Pandemic
  • 6.5. Manufacturers Strategic Initiatives
  • 6.6. Conclusion

7. By Product Type

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 7.1.2. Market Attractiveness Index, By Product Type
  • 7.2. Liquid Chromatography Spectrometer *
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.3. Gas chromatography Spectrometer
  • 7.4. Tandem Mass Spectrometer
  • 7.5. Matrix-Assisted Laser Desorption Ionization Time-Of-Flight
  • 7.6. Ion-Mobility Mass Spectrometry
  • 7.7. Others

8. By Application

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 8.1.2. Market Attractiveness Index, By Application
  • 8.2. Forensic Toxicology *
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 8.3. Proteomics Research
  • 8.4. Diagnostics
  • 8.5. Clinical Research
  • 8.6. Others

9. By Region

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 9.1.2. Market Attractiveness Index, By Region
  • 9.2. North America
    • 9.2.1. Introduction
    • 9.2.2. Key Region-Specific Dynamics
    • 9.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 9.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.2.5.1. The U.S.
      • 9.2.5.2. Canada
      • 9.2.5.3. Mexico
  • 9.3. Europe
    • 9.3.1. Introduction
    • 9.3.2. Key Region-Specific Dynamics
    • 9.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 9.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.3.5.1. Germany
      • 9.3.5.2. The U.K.
      • 9.3.5.3. France
      • 9.3.5.4. Italy
      • 9.3.5.5. Spain
      • 9.3.5.6. Rest of Europe
  • 9.4. South America
    • 9.4.1. Introduction
    • 9.4.2. Key Region-Specific Dynamics
    • 9.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 9.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.4.5.1. Brazil
      • 9.4.5.2. Argentina
      • 9.4.5.3. Rest of South America
  • 9.5. Asia-Pacific
    • 9.5.1. Introduction
    • 9.5.2. Key Region-Specific Dynamics
    • 9.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 9.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.5.5.1. China
      • 9.5.5.2. India
      • 9.5.5.3. Japan
      • 9.5.5.4. Australia
      • 9.5.5.5. Rest of Asia-Pacific
  • 9.6. Middle East and Africa
    • 9.6.1. Introduction
    • 9.6.2. Key Region-Specific Dynamics
    • 9.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 9.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application

10. Competitive Landscape

  • 10.1. Competitive Scenario
  • 10.2. Market Positioning/Share Analysis
  • 10.3. Mergers and Acquisitions Analysis

11. Company Profiles

  • 11.1. Agilent Technologies *
    • 11.1.1. Company Overview
    • 11.1.2. Product Type Portfolio and Description
    • 11.1.3. Financial Overview
    • 11.1.4. Key Developments
  • 11.2. Bruker Corporation
  • 11.3. Danaher Corporation
  • 11.4. Hitachi Ltd
  • 11.5. JEOL Ltd
  • 11.6. LECO Corporation
  • 11.7. MKS Instruments
  • 11.8. PerkinElmer Inc.
  • 11.9. Shimadzu Corporation
  • 11.10. Thermo Fisher Scientific Ltd

LIST NOT EXHAUSTIVE

12. Appendix

  • 12.1. About Us and Services
  • 12.2. Contact Us